Philip P Boudreau Abbott Laboratories (ABT) insider trading activity

Philip P Boudreau is EVP AND CFO of ABBOTT LABORATORIES. Currently has a direct ownership of 50,616 shares of ABT, which is worth approximately $6.79 Million. The most recent transaction as insider was on Sep 01, 2025, when has been sold 387 shares (Common shares without par value) at a price of $132.66 per share, resulting in proceeds of $51,339. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.6K

10.5% 3M change

29.9% 12M change

Total Value Held $6.79 Million

Philip P Boudreau Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 01 2025	SELL Payment of exercise price or tax liability	$51,339 $132.66 p/Share	387 Reduced 0.76%	50,616 Common shares without ...
Aug 08 2025	SELL Open market or private sale	$746,752 $134.55 p/Share	5,550 Reduced 9.81%	51,003 Common shares without ...
Feb 28 2025	SELL Payment of exercise price or tax liability	$666,849 $135.87 p/Share	4,908 Reduced 7.99%	56,553 Common shares without ...
Feb 25 2025	BUY Grant, award, or other acquisition	-	22,495 Added 26.79%	61,461 Common shares without ...
Sep 01 2024	SELL Payment of exercise price or tax liability	$43,835 $113.27 p/Share	387 Reduced 0.98%	38,966 Common shares without ...
Feb 29 2024	SELL Payment of exercise price or tax liability	$208,646 $120.05 p/Share	1,738 Reduced 4.23%	39,353 Common shares without ...
Feb 21 2024	BUY Grant, award, or other acquisition	-	23,024 Added 35.91%	41,091 Common shares without ...
Sep 01 2023	BUY Grant, award, or other acquisition	-	2,620 Added 12.66%	18,067 Common shares without ...
Jun 16 2023	SELL Open market or private sale	$848,000 $106.0 p/Share	8,000 Reduced 34.12%	15,447 Common shares without ...
Feb 28 2023	SELL Payment of exercise price or tax liability	$147,360 $99.77 p/Share	1,477 Reduced 5.93%	23,447 Common shares without ...
Feb 17 2023	BUY Grant, award, or other acquisition	-	4,855 Added 16.3%	24,924 Common shares without ...
Feb 28 2022	SELL Payment of exercise price or tax liability	$145,913 $122.41 p/Share	1,192 Reduced 5.61%	20,069 Common shares without ...
Feb 22 2022	SELL Payment of exercise price or tax liability	$112,819 $116.79 p/Share	966 Reduced 4.35%	21,261 Common shares without ...
Feb 18 2022	BUY Grant, award, or other acquisition	-	5,351 Added 19.4%	22,227 Common shares without ...
Oct 25 2021	SELL Open market or private sale	$1,011,920 $126.49 p/Share	8,000 Reduced 32.16%	16,876 Common shares without ...
Feb 26 2021	SELL Payment of exercise price or tax liability	$85,592 $121.58 p/Share	704 Reduced 2.75%	24,876 Common shares without ...
Feb 22 2021	SELL Payment of exercise price or tax liability	$115,288 $123.04 p/Share	937 Reduced 3.53%	25,580 Common shares without ...
Feb 19 2021	BUY Grant, award, or other acquisition	-	4,997 Added 15.86%	26,517 Common shares without ...
Feb 16 2021	SELL Payment of exercise price or tax liability	$120,921 $128.23 p/Share	943 Reduced 4.2%	21,520 Common shares without ...
Mar 13 2020	SELL Open market or private sale	$869,200 $82.0 p/Share	10,600 Reduced 32.06%	22,463 Common shares without ...

PPB

Philip P Boudreau

EVP AND CFO

Abbott Park, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Value

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT

Account